Super Religare Laboratories Ltd (SRL), a subsidiary of Fortis Healthcare Ltd, is looking to file its draft red herring prospectus (DRHP) with the securities market regulator SEBI to float a public ...
TO READ THE FULL STORY
- Definitive news, exclusives, analyses and videos
Exclusive reporting, expert analysis and commentary on PE/VC/M&A deals & dealmakers
Daily, weekly and monthly curated newsletters on the deal ecosystem in India
Breaking news alerts
Participation in marquee events at concessional rates
Comprehensive | Accurate | Unbiased | Impeccably sourced